Ilir Maraj, MD
Assistant Professor of Medicine (Cardiovascular Medicine)
Research & Publications
Biography
News
Coauthors
Selected Publications
- Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 InfectionHummel JP, Maraj I, Taoutel R, Chamoun R, Workman VK, Tran L, Abboud JM, Afif C, Chouairi S, Delvecchio A, Howes CJ, Enriquez AD, Akar JG. Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection. Circulation Arrhythmia And Electrophysiology 2020, 13: e008841-e008841. PMID: 32931318, PMCID: PMC7566294, DOI: 10.1161/circep.120.008841.
- Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycinMaraj I, Hummel JP, Taoutel R, Chamoun R, Workman V, Li C, Tran L, DelVecchio A, Howes C, Akar JG. Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycin. Journal Of Cardiovascular Electrophysiology 2020, 31: 1904-1907. PMID: 32485061, PMCID: PMC7300464, DOI: 10.1111/jce.14594.
- Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation AblationMaraj I, Gonzalez MD, Naccarelli GV. Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation. Journal Of Innovations In Cardiac Rhythm Management 2018, 9: 3274-3281. PMID: 32477818, PMCID: PMC7252752, DOI: 10.19102/icrm.2018.090801.
- A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today?Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal Of Cardiovascular Pharmacology And Therapeutics 2018, 24: 3-10. PMID: 29940780, DOI: 10.1177/1074248418784288.
- Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation AblationMaraj I, Gonzalez MD, Naccarelli GV. J Innov Cardiac Rhythm Manage. 2018;9(8)3274–3281
- Decrease in Radiation Exposure during Cardiac Implantable Electronic Device (CIED) Implantation with Modern Imaging PlatformChudow JJ, Maraj I, Zaremski L, Rojas R, Krumerman A, et al. Int J Clin Cardiol Res. 2018;2(3): 072-075
- Role of the left atrial appendage “stump” in persistent atrial fibrillationRomero J, Briceño DF, Grushko M, Maraj I, Grupposo V, Di Biase L. Role of the left atrial appendage “stump” in persistent atrial fibrillation. HeartRhythm Case Reports 2017, 4: 45-49. PMID: 29876286, PMCID: PMC5988474, DOI: 10.1016/j.hrcr.2017.08.008.
- Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis.Briceño DF, Romero J, Villablanca PA, Londoño A, Diaz JC, Maraj I, Batul SA, Madan N, Patel J, Jagannath A, Mohanty S, Mohanty P, Gianni C, Della Rocca D, Sabri A, Kim SG, Natale A, Di Biase L. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. EP Europace 2017, 20: 104-115. PMID: 28575378, DOI: 10.1093/europace/eux109.
- Ventricular Tachycardia in Ischemic Cardiomyopathy: Are You Certain You Are Ablating the Clinical VT?Romero J, Briceno DF, Maraj I, Grupposo V, Kim SG, Di Biase L EP Lab Digest 2017 ; 17(5)
- Use of vascular closure device is safe and effective in electrophysiological proceduresMaraj I, Budzikowski AS, Ali W, Mitre CA, Kassotis J. Use of vascular closure device is safe and effective in electrophysiological procedures. Journal Of Interventional Cardiac Electrophysiology 2015, 43: 193-195. PMID: 25921347, DOI: 10.1007/s10840-015-0005-5.
- Torsades De Pointes Induced by Methadone and Clonazepam UseAshkar A, Goldberg T, Maraj I, Masters A, McFarlane S. Torsades De Pointes Induced by Methadone and Clonazepam Use. International Journal Of Medical And Pharmaceutical Case Reports 2015, 2: 81-85. DOI: 10.9734/ijmpcr/2015/13517.
- Panobinostat, a Novel Histone Deacetylase (HiDAC) Inhibitor Enhances the Anti-Tumor Activity of Bortezomib (BTZ) In Rituximab-Chemotherapy Sensitive and Resistant Lymphoma Cell LinesHernandez-Ilizaliturri F, Mavis C, Maraj I, Chisti M, Gibbs J, Czuczman M. Panobinostat, a Novel Histone Deacetylase (HiDAC) Inhibitor Enhances the Anti-Tumor Activity of Bortezomib (BTZ) In Rituximab-Chemotherapy Sensitive and Resistant Lymphoma Cell Lines. Blood 2010, 116: 3936. DOI: 10.1182/blood.v116.21.3936.3936.
- The DAC Inhibitor, LBH589, Is Highly Effective in Both Rituximab-Sensitive and Rituximab-Resistant Lymphomas and Enhances the Anti-Tumor Activity of Bortezomib, Other Chemotherapy Agents, and Anti-CD20 Monoclonal Antibodies.Hernandez-Ilizaliturri F, Marvis C, Maraj I, Chisti M, Gibbs J, Czuczman M. The DAC Inhibitor, LBH589, Is Highly Effective in Both Rituximab-Sensitive and Rituximab-Resistant Lymphomas and Enhances the Anti-Tumor Activity of Bortezomib, Other Chemotherapy Agents, and Anti-CD20 Monoclonal Antibodies. Blood 2009, 114: 2715. DOI: 10.1182/blood.v114.22.2715.2715.
- Efficacy of the DAC inhibitor LBH589 in both rituximab-sensitive and rituximab-resistant lymphomas and effect on the antitumor activity of chemotherapy agents, monoclonal antibodies, and bortezomibMaraj I, Hernandez-Ilizaliturri F, Chisti M, Czuczman M. Efficacy of the DAC inhibitor LBH589 in both rituximab-sensitive and rituximab-resistant lymphomas and effect on the antitumor activity of chemotherapy agents, monoclonal antibodies, and bortezomib. Journal Of Clinical Oncology 2009, 27: 8576-8576. DOI: 10.1200/jco.2009.27.15_suppl.8576.
- The DAC Inhibitor LBH589 Is Highly Effective in Both “Therapy”-Sensitive and -Resistant Lymphomas and Enhances the Anti-Tumor Activity of Chemotherapy Agents, Monoclonal Antibodies, and BortezomibMaraj I, Hernandez-Ilizaliturri F, Chisti M, Czuczman M. The DAC Inhibitor LBH589 Is Highly Effective in Both “Therapy”-Sensitive and -Resistant Lymphomas and Enhances the Anti-Tumor Activity of Chemotherapy Agents, Monoclonal Antibodies, and Bortezomib. Blood 2008, 112: 4984. DOI: 10.1182/blood.v112.11.4984.4984.